Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism

Transplantation

Volumn 82, Issue 2, 2006, Pages 251-257

  Ito, Hiroshi ^a   Takeuchi, Yasuo ^a   Shaffer, Juanita ^a   Sykes, Megan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bone marrow; Chimerism; Costimulation; Tolerance; Xenotransplantation

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; OKT 4; OKT 8;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; FEMALE; GRAFT REJECTION; IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; MYELOABLATIVE CONDITIONING; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; RAT; T CELL DEPLETION; THYMUS; WHOLE BODY RADIATION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED F344; SKIN TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY IRRADIATION;

EID: 33746442833     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000226147.69877.6f     Document Type: Article

References (30)

1. Sharabi Y, Aksentijevich I, Sundt TM, et al. Specific tolerance induction across a xenogeneic barrier: production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. J Exp Med 1990; 172: 195.
2. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med 1989; 169: 493.
3. Tomita Y, Khan M, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087.
4. Nikolic B, Khan A, Sykes M. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: the importance of overcoming intrathymic alloresistance. Biol Blood Marrow Transplant 2001; 7: 144.
5. Nikolic B, Cooke DT, Zhao G, Sykes M. Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice. J Immunol 2001; 166: 1398.
6. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.
7. Wekerle T, Sayegh MH, Ito H, et al. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 1999; 68: 1348.
8. Ito H, Kurtz I, Shaffer J, Sykes M. CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. J Immunol 2001; 166: 2970.
9. Matsuura A, Ishii Y, Yuasa H, et al. Rat T lymphocyte antigens comparable with mouse Lyt-1 and Lyt-2,3 antigenic systems: characterization by monoclonal antibodies. J Immunol 1984; 132: 316.
10. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 1983; 131: 2445.
11. Sarmiento M, Glasebrook AL, Fitch FW. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J Exp Med 1980; 125: 2665.
12. Koo GC, Peppard IR. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma 1984; 3: 301.
13. Tomita Y, Lee LA, Sykes M. Engraftment of rat bone marrow and its role in negative selection of murine T cells in mice conditioned with a modified non-myeloablative regimen. Xenotransplantation 1994; 1: 109.
14. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150: 580.
15. Acha-Orbea H, Palmer E. Mls - a retrovirus exploits the immune system. Immunol Today 1991; 10: 356.
16. Tomonari K, Fairchild S. The genetic basis of negative selection of Tcrb-V11+ T cells. Immunogenetics 1991; 33: 157.
17. Dyson PJ, Knight AM, Fairchild S, et al. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature 1991; 349: 531.
18. Gordon EJ, Woda BA, Shultz LD, et al. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells. Transplantation 2001; 71: 319.
19. Gordon EJ, Markees TG, Phillips NE, et al. Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody. Diabetes 1998; 47: 1199.
20. Pierson RNI, Winn HJ, Russell PS, Auchincloss H Jr. Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med 1989; 170: 991.
21. Uchida T, Tomita Y, Anzai K, et al. Roles of CD4+ and CD8+ T cells in discordant skin xenograft rejection. Transplantation 1999; 68: 1721.
22. Iwakoshi NN, Mordes JP, Markees TG, et al. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164: 512.
23. Monk NJ, Hargreaves RE, Marsh JE, et al. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade. Nat Med 2003; 9: 1275.
24. Kurtz J, Ito H, Wekerle T, et al. Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells. Am J Transplant 2001; 1: 339.
25. Koyama I, Kawai T, Andrews D, et al. Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation 2004; 77: 460.
26. Adams AB, Shirasugi N, Jones TR, et al. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol 2005; 174: 542.
27. Nikolic B, Lei H, Pearson DA, et al. Role of intrathymic rat class II+ cells in maintaining deletional tolerance in xenogeneic rat->mouse bone marrow chimeras. Transplantation 1998; 65: 1216.
28. Lee LA, Sergio JJ, Sachs DH, Sykes M. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a nonmyeloablative conditioning regimen. Transplant Proc 1994; 26: 1197.
29. Gritsch HA, Sykes M. Host marrow has a competitive advantage which limits donor hematopoietic repopulation in mixed xenogeneic chimeras. Xenotransplantation 1996; 3: 312.
30. Van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 2.